Crossref
journal-article
Elsevier BV
The American Journal of Clinical Nutrition (78)
References
117
Referenced
788
{'year': '1998', 'series-title': 'Presenilins and Alzheimer’s disease.', 'key': '10.1093/ajcn/71.2.621s_bib1'}
/ Presenilins and Alzheimer’s disease. (1998)10.1038/39321
/ Nature / Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer’s disease by Wyss-Coray (1997){'year': '1999', 'series-title': 'Neuro-immune interactions and neurological and psychiatric disorders.', 'key': '10.1093/ajcn/71.2.621s_bib3'}
/ Neuro-immune interactions and neurological and psychiatric disorders. (1999)10.1007/BF02436085
/ Age / Free radical theory of aging: Alzheimer’s disease pathogenesis by Hartman (1995){'year': '1989', 'series-title': 'Free radicals in biology and medicine.', 'author': 'Halliwell', 'key': '10.1093/ajcn/71.2.621s_bib5'}
/ Free radicals in biology and medicine. by Halliwell (1989){'year': '1992', 'series-title': 'Free radicals in the brain.', 'key': '10.1093/ajcn/71.2.621s_bib6'}
/ Free radicals in the brain. (1992){'year': '1991', 'series-title': 'Oxidation damage and repair: chemical, biological and medical aspects.', 'author': 'Ames', 'key': '10.1093/ajcn/71.2.621s_bib7'}
/ Oxidation damage and repair: chemical, biological and medical aspects. by Ames (1991){'key': '10.1093/ajcn/71.2.621s_bib8', 'series-title': 'The molecular and genetic basis of neurological disease.', 'first-page': '1242', 'article-title': 'Glutathione in the brain: disorders of glutathione metabolism', 'author': 'Cooper', 'year': '1997'}
/ The molecular and genetic basis of neurological disease. / Glutathione in the brain: disorders of glutathione metabolism by Cooper (1997)10.1016/0163-7827(90)90002-3
/ Prog Lipid Res / The role of alterations in membrane lipid composition in enabling physiological adaptation of organisms to their physical environment by Hazel (1990)10.1046/j.1471-4159.1995.64062660.x
/ J Neurochem / Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer’s disease by Smith (1995)10.1016/0197-4580(95)00066-N
/ Neurobiol Aging / Are reactive oxygen species involved in Alzheimer’s disease? by Benzi (1995){'year': '1997', 'series-title': 'Mitochondria and free radicals in neurodegenerative diseases.', 'key': '10.1093/ajcn/71.2.621s_bib12'}
/ Mitochondria and free radicals in neurodegenerative diseases. (1997)10.1046/j.1471-4159.1995.65020710.x
/ J Neurochem / Transferrin and iron in normal, Alzheimer’s disease, and Parkinson’s disease brain regions by Loeffler (1995)10.1016/S0891-5849(96)00629-6
/ Free Radic Biol Med / Oxidative stress hypothesis in Alzheimer’s disease by Markesbery (1997)10.1073/pnas.94.18.9866
/ Proc Natl Acad Sci U S A / Iron accumulation in Alzheimer disease is a source of redox-generated free radicals by Smith (1997)10.1038/nm1196-1230
/ Nat Med / Serum levels of the iron binding protein p97 are elevated in Alzheimer’s disease by Kennard (1996)10.1007/BF00688530
/ Acta Neuropathol (Berl) / Intranuclear aluminum content in Alzheimer’s disease, dialysis encephalopathy, and experimental aluminum encephalopathy by Crapper (1980)10.1097/00002093-199601030-00006
/ Alzheimer Dis Assoc Disord / Content of brain aluminum is not elevated in Alzheimer disease by Bjertness (1996)10.1126/science.271.5254.1406
/ Science / The amyloid precursor protein of Alzheimer’s disease in the reduction of copper (II) to copper (I) by Multhaup (1996)10.1016/S0753-3322(97)86907-7
/ Biomed Pharmacother / Amyloid precursor protein, copper and Alzheimer’s disease by Multhaup (1997){'key': '10.1093/ajcn/71.2.621s_bib21', 'first-page': '147', 'article-title': 'Oxidative stress in Alzheimer’s disease', 'volume': '1', 'author': 'Multhaup', 'year': '1998', 'journal-title': 'Alzheimer Rep'}
/ Alzheimer Rep / Oxidative stress in Alzheimer’s disease by Multhaup (1998)10.1093/ajcn/63.5.797
/ Am J Clin Nutr / Copper biochemistry and molecular biology by Linder (1996)10.1016/S0022-510X(96)00203-1
/ J Neurol Sci / Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer’s disease: possible relation to oxidative stress by Deibel (1997)10.1126/science.8073293
/ Science / Rapid induction of Alzheimer Aβ amyloid formation by zinc by Bush (1994)10.1146/annurev.neuro.21.1.347
/ Annu Rev Neurosci / Zinc and brain injury by Choi (1998)10.1002/ana.410360510
/ Ann Neurol / Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease by Mecocci (1994)10.1046/j.1471-4159.1995.65052146.x
/ J Neurochem / Brain regional correspondence between Alzheimer’s disease histopathology and biomarkers of protein oxidation by Hensey (1995)10.1016/0006-8993(94)91670-5
/ Brain Res / Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer’s disease by Palmer (1994)10.1212/WNL.45.8.1594
/ Neurology / Elevated thiobarbituric acid–reactive substances and antioxidant enzyme activity in the brain in Alzheimer’s disease by Lovell (1995)10.1006/exnr.1997.6750
/ Exp Neurol / Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer’s disease by Marcus (1998)10.1016/0024-3205(96)00334-7
/ Life Sci / Evidence against the involvement of reactive oxygen species in the pathogenesis of neuronal death in Down’s syndrome and Alzheimer’s disease by Hayn (1996)10.1046/j.1471-4159.1997.68052061.x
/ J Neurochem / An assessment of oxidative damage to proteins, lipids and DNA in the brain from patients with Alzheimer’s disease by Lyras (1997){'key': '10.1093/ajcn/71.2.621s_bib33', 'series-title': 'Ginkgo biloba extract (EGb 761) study: lesson from cell biology.', 'first-page': '69', 'article-title': 'Apolipoprotein E, oxidative stress and EGb 761 in Alzheimer’s disease brain', 'author': 'Ramassamy', 'year': '1998'}
/ Ginkgo biloba extract (EGb 761) study: lesson from cell biology. / Apolipoprotein E, oxidative stress and EGb 761 in Alzheimer’s disease brain by Ramassamy (1998)10.1073/pnas.91.16.7787
/ Proc Natl Acad Sci U S A / Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress by Yan (1994){'key': '10.1093/ajcn/71.2.621s_bib35', 'first-page': '21', 'article-title': 'Evidence for neuronal oxidative damage in Alzheimer’s disease', 'volume': '149', 'author': 'Good', 'year': '1996', 'journal-title': 'Am J Pathol'}
/ Am J Pathol / Evidence for neuronal oxidative damage in Alzheimer’s disease by Good (1996)10.1523/JNEUROSCI.17-08-02653.1997
/ J Neurosci / Widespread peroxynitrite-mediated damage in Alzheimer’s disease by Smith (1997)10.1038/382120b0
/ Nature / Oxidative damage in Alzheimer’s by Smith (1996)10.1073/pnas.91.12.5710
/ Proc Natl Acad Sci U S A / Advanced Maillard reaction end products are associated with Alzheimer disease pathology by Smith (1994){'key': '10.1093/ajcn/71.2.621s_bib39', 'first-page': '621', 'article-title': 'Immunohistochemical evidence of antioxidant stress in Alzheimer’s disease', 'volume': '140', 'author': 'Pappolla', 'year': '1992', 'journal-title': 'Am J Pathol'}
/ Am J Pathol / Immunohistochemical evidence of antioxidant stress in Alzheimer’s disease by Pappolla (1992){'key': '10.1093/ajcn/71.2.621s_bib40', 'first-page': '42', 'article-title': 'Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer’s disease', 'volume': '145', 'author': 'Smith', 'year': '1994', 'journal-title': 'Am J Pathol'}
/ Am J Pathol / Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer’s disease by Smith (1994)10.1002/ana.410370609
/ Ann Neurol / Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain by Schipper (1995)10.1038/378776a0
/ Nature / Apoptosis and increased generation of reactive oxygen species in Down’s syndrome neurons in vitro by Busciglio (1995)10.1073/pnas.89.5.1671
/ Proc Natl Acad Sci U S A / Evidence for a membrane defect in Alzheimer disease brain by Nitsch (1992)10.1016/S0197-4580(98)00009-8
/ Neurobiol Aging / Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer’s disease by Markesbery (1998)10.1046/j.1471-4159.1997.68010255.x
/ J Neurochem / A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide by Mark (1997)10.1016/0197-4580(95)00063-K
/ Neurobiol Aging / Free radicals and disruption of neuronal ion homeostasis in AD: a role for amyloid β-peptide? by Mattson (1995)10.1523/JNEUROSCI.15-10-06377.1995
/ J Neurosci / Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-d-aspartate by Dugan (1995)10.1523/JNEUROSCI.15-05-03318.1995
/ J Neurosci / Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation by Reynolds (1995)10.1523/JNEUROSCI.16-08-02479.1996
/ J Neurosci / Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice by Dawson (1996)10.1002/ana.410440322
/ Ann Neurol / Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer’s disease by Montine (1998)10.1073/pnas.91.11.4766
/ Proc Natl Acad Sci U S A / Advanced glycation end products contribute to amyloidosis in Alzheimer disease by Vitek (1994)10.1038/370247a0
/ Nature / A glycation connection by Harrington (1994)10.1016/0166-2236(95)93897-7
/ Trends Neurosci / Radical AGEing in Alzheimer’s disease by Smith (1995)10.1038/373481a0
/ Nature / A tombstone in Alzheimer’s? by Mattson (1995)10.1038/382685a0
/ Nature / RAGE and amyloid-β peptide neurotoxicity in Alzheimer’s disease by Yan (1996)10.1073/pnas.94.10.5296
/ Proc Natl Acad Sci U S A / Amyloid-β peptide-receptor for advanced glycation end product interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease by Yan (1997)10.1046/j.1471-4159.1996.66020869.x
/ J Neurochem / Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid β-peptide toxicity by Goodman (1996){'key': '10.1093/ajcn/71.2.621s_bib58', 'series-title': 'Pharmacological treatment of Alzheimer’s disease: molecular and neurobiological foundations.', 'first-page': '239', 'article-title': 'Amyloid cytotoxicity and Alzheimer’s disease: roles of membrane oxidation and perturbed ion homeostasis', 'author': 'Mattson', 'year': '1997'}
/ Pharmacological treatment of Alzheimer’s disease: molecular and neurobiological foundations. / Amyloid cytotoxicity and Alzheimer’s disease: roles of membrane oxidation and perturbed ion homeostasis by Mattson (1997){'key': '10.1093/ajcn/71.2.621s_bib59', 'series-title': 'Neuro-immune interactions and neurological and psychiatric disorders.', 'first-page': '57', 'article-title': 'Mechanistic and metaphorical connections between NF-κB and the secreted Alzheimer’s β-amyloid precursor protein', 'author': 'Barger', 'year': '1999'}
/ Neuro-immune interactions and neurological and psychiatric disorders. / Mechanistic and metaphorical connections between NF-κB and the secreted Alzheimer’s β-amyloid precursor protein by Barger (1999)10.1038/sj.mp.4000295
/ Mol Psychol / Transcription factor NF-κB: friend or foe of neurons? by Lezoualc’h (1998)10.1016/0006-291X(92)90837-B
/ Biochem Biophys Res Commun / Vitamin E protects nerve cells from amyloid β protein toxicity by Behl (1992)10.1016/0092-8674(94)90131-7
/ Cell / Hydrogen peroxide mediates amyloid β protein toxicity by Behl (1994)10.1523/JNEUROSCI.16-02-00497.1996
/ J Neurosci / Increased antioxidant enzyme activity in amyloid β protein-resistant cells by Sagara (1996)10.1073/pnas.92.6.1989
/ Proc Natl Acad Sci U S A / Amyloid peptides are toxic via a common oxidative mechanism by Schubert (1995){'key': '10.1093/ajcn/71.2.621s_bib65', 'series-title': 'Ginkgo biloba extract (EGb 761) study: lesson from cell biology. Advances in EGb 761 research. Vol 7.', 'first-page': '85', 'article-title': 'Ginkgo biloba extract (EGb 761) prevents cell death induced by oxidative stress in hippocampal neuronal cell cultures', 'author': 'Bastianetto', 'year': '1998'}
/ Ginkgo biloba extract (EGb 761) study: lesson from cell biology. Advances in EGb 761 research. Vol 7. / Ginkgo biloba extract (EGb 761) prevents cell death induced by oxidative stress in hippocampal neuronal cell cultures by Bastianetto (1998)10.1523/JNEUROSCI.17-05-01683.1997
/ J Neurosci / Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide by Pappolla (1997)10.1073/pnas.93.6.2312
/ Proc Natl Acad Sci U S A / β-amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger by Bruce (1996){'key': '10.1093/ajcn/71.2.621s_bib68', 'first-page': '1456', 'article-title': 'Ginkgo biloba extract (EGb 761) protects in vitro rat hippocampal cells against toxicity induced by β-amyloid peptides', 'volume': '24', 'author': 'Bastianetto', 'year': '1998', 'journal-title': 'Soc Neurosci'}
/ Soc Neurosci / Ginkgo biloba extract (EGb 761) protects in vitro rat hippocampal cells against toxicity induced by β-amyloid peptides by Bastianetto (1998)10.1016/S0021-9258(19)37174-1
/ J Biol Chem / Amyloidogenicity of βA4 and βA4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation by Dyrks (1992)10.1038/380168a0
/ Nature / β-amyloid-mediated vasoactivity and vascular endothelial damage by Thomas (1996)10.1073/pnas.91.8.3270
/ Proc Natl Acad Sci U S A / A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer’s disease by Hensley (1994)10.1006/bbrc.1994.1508
/ Biochem Biophys Res Commun / β-amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer’s disease by Butterfield (1994)10.1523/JNEUROSCI.17-07-02284.1997
/ J Neurosci / Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia by McDonald (1997)10.1038/374647a0
/ Nature / Activation of microglial cells by β-amyloid protein and interferon gamma by Meda (1995)10.1073/pnas.92.20.9328
/ Proc Natl Acad Sci U S A / TNFα and TNFβ protect hippocampal neurons against amyloid β-peptide toxicity: evidence for involvement of a κB-binding factor and attenuation of peroxide and CaR+ accumulation by Barger (1995){'key': '10.1093/ajcn/71.2.621s_bib76', 'first-page': '125', 'article-title': 'Mechanism of amyloid beta protein induced neuronal cell death: current concepts and future perspectives', 'volume': '49', 'author': 'Behl', 'year': '1997', 'journal-title': 'J Neural Transm Suppl'}
/ J Neural Transm Suppl / Mechanism of amyloid beta protein induced neuronal cell death: current concepts and future perspectives by Behl (1997)10.1523/JNEUROSCI.18-09-03224.1998
/ J Neurosci / High constitutive NF-κB activity mediates resistance to oxidative stress in neuronal cells by Lezoualc’h (1998)10.1126/science.274.5291.1383
/ Science / Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation by Grilli (1996)10.1038/nm0197-20
/ Nat Med / Janus faces of NF-κB: neurodestruction versus neuroprotection by Lipton (1997)10.1016/0166-2236(94)90156-2
/ Trends Neurosci / Apolipoprotein E in animal models of CNS injury and in Alzheimer’s disease by Poirier (1994)10.1038/ng0996-55
/ Nat Genet / Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides by Miyata (1996){'key': '10.1093/ajcn/71.2.621s_bib82', 'series-title': 'Ginkgo biloba extract (EGb 761) study: lessons from cell biology.', 'first-page': '57', 'article-title': 'Oxidation of human apolipoprotein E: isoforms susceptibility and protection with Ginkgo biloba EGb 761 extract', 'author': 'Leininger-Muller', 'year': '1998'}
/ Ginkgo biloba extract (EGb 761) study: lessons from cell biology. / Oxidation of human apolipoprotein E: isoforms susceptibility and protection with Ginkgo biloba EGb 761 extract by Leininger-Muller (1998)10.1002/ana.410380304
/ Ann Neurol / Aging, energy, and oxidative stress in neurodegenerative diseases by Beal (1995)10.1046/j.1471-4159.1994.63062179.x
/ J Neurochem / Cortical cytochrome oxidase activity is reduced in Alzheimer’s disease by Mutisaya (1994)10.1097/00005072-199311000-00004
/ J Neuropathol Exp Neurol / Functional alterations in Alzheimer’s disease: diminution of cytochrome oxidase in the hippocampal formation by Simonian (1993)10.1016/0169-328X(94)90147-3
/ Mol Brain Res / Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer’s disease by Chandrasekaran (1994)10.1212/WNL.45.3.482
/ Neurology / Cytochrome c oxidase in Alzheimer’s disease brain: purification and characterization by Parker (1995){'key': '10.1093/ajcn/71.2.621s_bib88', 'first-page': '979', 'article-title': 'Production of reactive oxygen species correlates with decreased cytochrome oxidase activity in Alzheimer’s disease cybrids', 'volume': '21', 'author': 'Lakis', 'year': '1995', 'journal-title': 'Soc Neurosci'}
/ Soc Neurosci / Production of reactive oxygen species correlates with decreased cytochrome oxidase activity in Alzheimer’s disease cybrids by Lakis (1995)10.1016/S0959-4388(96)80100-0
/ Curr Opin Neurobiol / Mitochondria, free radicals, and neurodegeneration by Beal (1996)10.1212/WNL.49.4.918
/ Neurology / Cybrids in Alzheimer’s disease: a cellular model of the disease? by Swerdlow (1997)10.1073/pnas.93.3.1314
/ Proc Natl Acad Sci U S A / Transfer of β-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle by Askanas (1996)10.1073/pnas.94.9.4526
/ Proc Natl Acad Sci U S A / Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease by Davis (1997)10.1073/pnas.94.26.14894
/ Proc Natl Acad Sci U S A / Apparent mtDNA heteroplasmy in Alzheimer’s disease patients and in normals due to PCR amplification of nucleus-embedded mtDNA pseudogenes by Hirano (1997)10.1073/pnas.94.26.14900
/ Proc Natl Acad Sci U S A / Ancient mtDNA sequences in the human nuclear genome: a potential source of errors in identifying pathogenic mutations by Wallace (1997)10.1073/pnas.95.20.12069-b
/ Proc Natl Acad Sci U S A / Retraction by Davis (1998){'key': '10.1093/ajcn/71.2.621s_bib96', 'series-title': 'Alzheimer’s disease. Cause(s), diagnosis, treatment and care.', 'first-page': '187', 'article-title': 'Cerebral metabolic impairments', 'author': 'Blass', 'year': '1996'}
/ Alzheimer’s disease. Cause(s), diagnosis, treatment and care. / Cerebral metabolic impairments by Blass (1996)10.1007/s100480050002
/ Neurogenetics / Oxidative phosphorylation defects and Alzheimer’s disease by Shoffner (1997)10.1002/ana.410350311
/ Ann Neurol / Abnormality of the α-ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer’s disease by Sheu (1994){'key': '10.1093/ajcn/71.2.621s_bib99', 'first-page': '296', 'article-title': 'Positron emission tomography in Alzheimer’s disease in relation to disease pathogenesis: critical review', 'volume': '3', 'author': 'Rapoport', 'year': '1991', 'journal-title': 'Cerebrovasc Brain Metab Rev'}
/ Cerebrovasc Brain Metab Rev / Positron emission tomography in Alzheimer’s disease in relation to disease pathogenesis: critical review by Rapoport (1991)10.1016/0006-3223(96)84482-9
/ Biol Psychiatry / Brain stimulation reverses metabolic reductions in Alzheimer disease by Pietrini (1996)10.1006/neur.1996.0065
/ Neurodegeneration / Brain energy metabolism, cognitive function and down-regulated oxidative phosphorylation in Alzheimer’s disease by Rapoport (1996){'key': '10.1093/ajcn/71.2.621s_bib102', 'series-title': 'De la neurophysiologie à la maladie d’Alzheimer. (The neurophysiology of Alzheimer disease.)', 'first-page': '165', 'article-title': 'Deux stades, réversible et irréversible, de l’insuffisance fonctionnelle dans le cerveau alzheimerien. (Two stages, reversible and irreversible of functional insufficiency in the Alzheimer brain.)', 'author': 'Rapoport', 'year': '1997'}
/ De la neurophysiologie à la maladie d’Alzheimer. (The neurophysiology of Alzheimer disease.) / Deux stades, réversible et irréversible, de l’insuffisance fonctionnelle dans le cerveau alzheimerien. (Two stages, reversible and irreversible of functional insufficiency in the Alzheimer brain.) by Rapoport (1997)10.1016/0140-6736(91)92978-B
/ Lancet / Intramuscular desferrioxamine in patients with Alzheimer’s disease by Crapper McLachlan (1991)10.1056/NEJM199704243361704
/ N Engl J Med / A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease by Sano (1997)10.1055/s-2007-979544
/ Pharmacopsychiatry / Proofs of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia by Kanowski (1996)10.1001/jama.1997.03550160047037
/ JAMA / A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia by Le Bars (1997)10.1001/archneur.55.11.1409
/ Arch Neurol / The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease by Oken (1998){'year': '1998', 'series-title': 'Ginkgo biloba extract (EGb 761). From chemistry to the clinic.', 'author': 'DeFeudis', 'key': '10.1093/ajcn/71.2.621s_bib108'}
/ Ginkgo biloba extract (EGb 761). From chemistry to the clinic. by DeFeudis (1998)10.1016/S0928-4257(97)82409-6
/ J Physiol (Paris) / Effects of Ginkgo biloba extract (EGb 761) on learning and possible actions on aging by Cohen-Salmon (1997)10.1016/0197-4580(95)00049-K
/ Neurobiol Aging / Delayed onset of Alzheimer’s disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs by Breitner (1995)10.1212/WNL.45.1.51
/ Neurology / Nonsteroidal anti-inflammatory drugs in Alzheimer’s disease by Rich (1995)10.1006/bbrc.1995.2647
/ Biochem Biophys Res Commun / 17-β estradiol protects neurons from oxidative stress-induced cell death in vitro by Behl (1995)10.1046/j.1471-4159.1996.66020869.x
/ J Neurochem / Estrogens attenuate and cortisone exacerbates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons by Goodman (1996){'key': '10.1093/ajcn/71.2.621s_bib114', 'first-page': '348', 'article-title': 'Diets high in antioxidant activity prevent the deleterious effects of oxidative stress on signal transduction and nerve growth factor (NGF)', 'volume': '23', 'author': 'Chadman', 'year': '1997', 'journal-title': 'Soc Neurosci'}
/ Soc Neurosci / Diets high in antioxidant activity prevent the deleterious effects of oxidative stress on signal transduction and nerve growth factor (NGF) by Chadman (1997)10.1136/bmj.312.7031.608
/ BMJ / Cognitive impairment and mortality in a cohort of elderly people by Gale (1996)10.1001/jama.1995.03520380049034
/ JAMA / Protective effect of fruits and vegetables on development of stroke in men by Gilman (1995)10.1038/nm0798-827
/ Nat Med / Aging renders the brain vulnerable to amyloid β-protein toxicity by Geula (1998)
Dates
Type | When |
---|---|
Created | 7 years, 6 months ago (Feb. 20, 2018, 3:22 p.m.) |
Deposited | 8 months, 3 weeks ago (Dec. 11, 2024, 7:49 p.m.) |
Indexed | 3 days, 15 hours ago (Aug. 29, 2025, 5:51 a.m.) |
Issued | 25 years, 7 months ago (Feb. 1, 2000) |
Published | 25 years, 7 months ago (Feb. 1, 2000) |
Published Print | 25 years, 7 months ago (Feb. 1, 2000) |
@article{Christen_2000, title={Oxidative stress and Alzheimer disease}, volume={71}, ISSN={0002-9165}, url={http://dx.doi.org/10.1093/ajcn/71.2.621s}, DOI={10.1093/ajcn/71.2.621s}, number={2}, journal={The American Journal of Clinical Nutrition}, publisher={Elsevier BV}, author={Christen, Yves}, year={2000}, month=feb, pages={621S-629S} }